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Multiple transcription factors guide the development
of mature functional natural killer (NK) cells, yet little
is known about their function. We used global gene
expression and genome-wide binding analyses
combinedwith developmental and functional studies
to unveil three roles for the ETS1 transcription factor
in NK cells. ETS1 functions at the earliest stages of
NK cell development to promote expression of crit-
ical transcriptional regulators including T-BET and
ID2, NK cell receptors (NKRs) including NKp46,
Ly49H, and Ly49D, and signalingmolecules essential
for NKR function. As a consequence,Ets1/NKcells
fail to degranulate after stimulation through acti-
vating NKRs. Nonetheless, these cells are hyperre-
sponsive to cytokines and have characteristics of
chronic stimulation including increased expression
of inhibitory NKRs and multiple activation-associ-
ated genes. Therefore, ETS1 regulates a broad
gene expression program in NK cells that promotes
target cell recognition while limiting cytokine-driven
activation.
INTRODUCTION
Natural killer (NK) cells are lymphocytes that utilize germline-
encoded activating and inhibitory receptors (NKRs) to recognize
virus-infected, transformed, and stressed cells. NK cells also
contribute to adaptive immune responses through the produc-
tion of inflammatory cytokines and by promoting the maturation
or destruction of immature dendritic cells (Vivier et al., 2011).
NK cells are activated when inhibitory NKRs recognizing clas-
sical or nonclassical major histocompatibility complex (MHC)
antigens fail to be engaged (‘‘missing-self’’ recognition) and/or
when activating NKRs detect their ligands, thereby altering the
balance between activating and inhibitory signals (Lanier,2005). Themechanisms controlling the threshold for NK cell acti-
vation are not well understood but inhibitory receptor signaling
appears to play a role in ‘‘licensing’’ or ‘‘arming or disarming’’
developing NK cells so that engagement of activating receptors
results in a functional response (Joncker and Raulet, 2008;
Yokoyama and Kim, 2006). NK cell immune deficiency results
in susceptibility to infection and, although rare, NK cell malignan-
cies are aggressive and difficult to treat. Therefore, under-
standing the mechanisms that control the development and
function of NK cells has both basic biological and clinical
significance.
NK cells develop in the bone marrow (BM) from common
lymphoid progenitors (CLPs) through three major stages defined
by expression of CD122 (interleukin 2 [IL-2] and IL-15 receptor-b
chain), NK1.1 (an activating NKR expressed in only some strains
of mice), and DX5 (integrin a2) (Kim et al., 2002; Rosmaraki et al.,
2001). NK progenitors (NKPs) are CD122+ and lack NK1.1 and
DX5 (CD49b). CD27, CD127, and CD244 mark a subset of
NKPs (rNKPs) enriched for NK cell potential as well as pre-
NKP cells, a CD122 intermediate betweenCLP and rNKP (Fath-
man et al., 2011). Acquisition of NK1.1 occurs at the immature
NK (iNK) cell stage where multiple NKRs initiate expression
and the cells become dependent on IL-15 for survival (Vosshen-
rich et al., 2005). Themature NK (mNK) cell stage is defined by an
increase in DX5, IL-15-driven expansion, and licensing or arming
of NK cells (Kim et al., 2002; Rosmaraki et al., 2001). Further
maturation correlates with increased expression of CD11b and
decreased expression of CD27 (Chiossone et al., 2009; Kim
et al., 2002).
Although stages in the NK cell program have been character-
ized, little is known about the transcriptional networks that
establish the NK cell gene program or promote NK cell function.
A few transcription factors have been identified that play a major
role in the generation of mNK cells including T-BET and EOMES
(Gordon et al., 2012; Intlekofer et al., 2005), ETS1 (Barton et al.,
1998), E4BP4 (Gascoyne et al., 2009; Kamizono et al., 2009),
TOX1 (Aliahmad et al., 2010), and ID2 (Boos et al., 2007; Yokota
et al., 1999). Although mNK cells largely fail to develop in
these strains, the mechanisms underlying the observed pheno-
types are not known. Moreover, the transcriptional programsImmunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc. 921
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ETS1 Targets in NK Cellscontrolling NKR expression and NK cell maturation or function
remain to be determined, although a few factors such as TCF1,
MEF1, and BLIMP1 play a role (Held et al., 1999; Kallies et al.,
2011; Lacorazza et al., 2002).
ETS1, the founding member of the ETS family of transcription
factors, has been known to be important for development of
mNK cells for nearly 14 years and yet insight into how ETS1 func-
tions is completely lacking (Barton et al., 1998). It is not known
when ETS1 becomes essential and no target genes have been
identified in the NK cell lineage. Here, we demonstrated that
ETS1 functioned as early as the pre-NKP cell stage and that
ETS1 regulated abroad spectrumofNKcell genes including tran-
scription factors, NKRs, and signalingmolecules.We place ETS1
within a transcriptional network specifying the NK cell fate with
direct targets including Tbx21 (T-BET) and Idb2 (ID2). Ets1/
mNK cells failed to lyse NK cell targets and we demonstrated
decreased expression or function of multiple activating NKRs.
However, Ets1/ mNK cells had characteristics of chronic acti-
vation including increased expression of inhibitory NKRs Ly49G2
and Ly49E, increased expression of the IL-15 responsive gene
Nfli3, encoding E4BP4, and increased Ikzf2, encoding HELIOS,
a transcription factor associated with NK cell hyperresponsive-
ness (Narni-Mancinelli et al., 2012). Moreover, Ets1/mNK cells
showed an augmented response to IL-15 in vitro. Our data
provide insight into the molecular mechanisms underlying the
requirement for ETS1 in NK cell development and function and
provide a foundation for building the regulatory networks that
control this important innate immune cell lineage.
RESULTS
ETS1 Functions at the Earliest Stages of NK Cell
Development
Ets1/mice have a reduced number of mNK cells (Barton et al.,
1998) but it is not known when or how ETS1 functions in the
NK cell lineage. To begin to address this issue, we rigorously
analyzed NK cell development in Ets1/ mice. As expected, in
the BM and spleen of Ets1/ mice, mNK cell numbers were
decreased by 90% and 80%, respectively, relative to wild-type
(WT) mNK cells (Figures 1A and 1C; Figure S1 available online;
Barton et al., 1998). There was a decrease in the frequency of
the most mature splenic mNK cells (CD27CD11b+) but a
similar frequency of these cells expressed KLRG1 (Figure S1;
Chiossone et al., 2009). ETS1 was required for development of
approximately 50% of iNK cells but NKP numbers were similar
to WT (Figures 1A and 1C). However, Ets1/ rNKPs (LinCD27+
CD244+FLT3CD127+CD122+) were decreased by nearly 50%
and their precursor pre-NKPs (LinCD27+CD244+FLT3
CD127+CD122) were decreased by 20% (Figures 1B and 1D).
Ets1/ mice also showed an approximate 50% decrease in
pre-pro-NKb cells (LinCD117Sca1+CD127+FLT3) (Figure S1;
Carotta et al., 2011). These data reveal a function for ETS1 at the
earliest stages of NK cell development.
To determine whether the requirements for ETS1 were cell
autonomous, we created mixed BM chimeras where Ets1/
cells developed in competition with WT cells. Both WT
(CD45.2+) and Ets1/ (CD45.2+) BM gave rise to hematopoietic
stem cells (HSCs), multipotent progenitors (MPPs), lymphoid
primed MPPs (LMPPs), and CLPs that competed well with WT922 Immunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc.(CD45.1) cells (Figures 1E and S1). However, there was
a >80% decline in NK lineage cells by the iNK cell stage (Figures
1E and S1). Therefore, there was a cell-intrinsic requirement for
ETS1 for NK cell development.
ETS1 Regulates the NK Cell Transcriptome
To gain an understanding of how ETS1 functions in NK cells,
we performed a global analysis of gene expression in mNK cells
isolated from Rag2/Ets1+/+ and Rag2/Ets1/ mice.
We used the Rag2/ background to avoid contamination of
NK cells with activated T lymphocytes (Stewart et al., 2007).
We identified 216 genes that were decreased by 50%
or increased by 2-fold by the absence of ETS1 (Figure 2A;
Table S1). The distribution of these differentially expressed
genes was examined across WT multipotent progenitor cell
populations, pro-B cells, and CD4+ T cells. Nearly 50% of
ETS1-dependent genes were expressed in CD4+ T cells but
not in the other populations (Figure 2A). This finding suggested
that ETS1 regulates a gene program shared with T cells, which
also required ETS1 at multiple stages of development (Hollen-
horst et al., 2009). However, slightly >50% of ETS1-dependent
genes were unique to the NK cell lineage (Figure 2A).
To distinguish direct from possibly indirect targets of ETS1,
we considered a genome-wide analysis of ETS1 binding by
ChIP-sequencing (ChIP-seq). However, such an approach was
hampered by the low abundance of NK cells in vivo and because
ETS1 was downregulated in NK cell lines and primary NK cells
cultured in vitro, limiting the use of in vitro expanded cells (Fig-
ure S2). Given that a set of ETS1-dependent NK cell genes
was expressed in CD4+ T cells, we began by examining the
overlap between these genes and ETS1 binding in a human
CD4+ T cell line as determined by ChIP-seq (Hollenhorst et al.,
2007). Of the 216 ETS1-dependent NK cell genes, 167 had
human orthologs and 106 of these (63.5%) were associated
with ETS1 binding in the T cell line (Figure 2B). Therefore, 106
(49%) of the differentially expressed genes we identified are
high-probability ETS1 target genes (Table S2).
We next determined whether any unique binding motifs were
enriched among the sequences associated with ETS1 binding
at ETS1-dependent NK cell genes via MEME (Bailey et al.,
2009). An ETS binding motif was enriched that was nearly
identical to the motif previously associated with ETS1-specific
binding at distal (enhancer) sites (Figure 2C). These are sites
that failed to be bound by ELF1 and GABPa in the CD4+ T cell
line (Hollenhorst et al., 2009).
ETS1 Is Required for Proper Expression of Multiple
NKRs, Signaling Molecules, and Transcription Factors
KEGG pathway analysis of the differentially expressed genes
revealed their involvement in NK cell cytotoxicity and in T cell
receptor-, chemokine-, and Janus kinase-signal transducer
and activator of transcription (Jak-STAT)-signaling pathways
(Figure 2D; Huang et al., 2009). A selected set of NK cell-
associated genes is shown in Figure 3A and among these Ltb,
Tbx21, Itk, Slamf6, Jak1, CD27, Lck, and Lair1 were bound by
ETS1 in the CD4+ T cell line. We demonstrated that ETS1 binds
directly to the Tbx21 andCd122 genes inmNK cells by ChIP (Fig-
ure 3D), confirming that these are direct targets. We confirmed
differential expression of Ncr1 (NKp46), Cd122, Idb2, Ltb,
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Figure 1. ETS1 Functions at the Earliest Stages of NK Cell Development
(A and B) Flow cytometry analysis of Ets1+/+ and Ets1/ BM using (A) NK1.1 and DX5 to identify NKP (NK1.1DX5), iNK (NK1.1+DX5), and mNK (NK1.1+DX5+)
cells in CD122+ Lineage (CD19CD3TCR-bCD4CD8TER119) cells or (B) FLT3 and CD122 to identify CLP (FLT3+CD122), pre-NKP (FLT3CD122), and
rNKP (FLT3CD122+) in LinCD27+CD244+CD127+ cells. The frequency of cells in the gated areas is indicated.
(C and D) The total number of (C) BMNKP, iNK, andmNK and splenic mNK (sNK) or (D) CLP, pre-NKP, and rNKP is presented. Each circle represents onemouse,
horizontal bar indicates average. Closed circles, Ets1+/+ mice; open circles, Ets1/ mice. n = 4–7 for each genotype. *p < 0.05, **p < 0.01, ***p < 0.001 by
a Student’s t test, #p < 0.05 by a paired t test but not significant with a standard t test.
(E) Relative contribution of Ets1+/+ and Ets1/ CD45.2+ cells in HSCs, MPPs, LMPPs, CLPs, NKP, iNK, and mNK from mixed BM chimeras with WT CD45.1+
competitors. Squares, Ets1+/+; diamonds, Ets1/. n = 9 except CLPs where n = 7.
See Figure S1 for analysis of splenic mNK cells, pre-pro-NK cells, and flow cytometery analysis of BM chimeras.
Immunity
ETS1 Targets in NK CellsLair1, and Tbx21 mRNA in LinCD122+DX5 pro-NK cells
(NKP+iNK) and mNK cells by quantitative polymerase chain
reaction (qPCR) (Figure 3B). Reduced expression of Ltb and
Tbx21 mRNA was also confirmed in Ets1/ NKPs (Figure 3C).
Therefore, Ets1 deficiency results in decreased expression of
critical regulators of NK cell development including transcription
factors and NKRs.
ETS1 Regulates Idb2 in NK Cells and Their Progenitors
The Idb2 gene, which encodes ID2, is required for proper devel-
opment beyond the iNK cell stage (Boos et al., 2007) and itsexpression was dependent on ETS1 in mNK cells (Figure 3A).
However, Idb2 was not bound by ETS1 in the CD4+ T cell line,
raising the possibility that Idb2 is not a direct target of ETS1.
To gain insight into the mechanisms controlling Idb2 expression,
we performed mutational analysis of Idb2 promoter-luciferase
reporters in an NKP cell line (Rodewald et al., 1992). We found
that Idb2 reporters containing at least 225 bp of sequence
upstream of the transcription start site (TSS) gave maximal lucif-
erase activity (Figure 4A). In contrast, truncation to 130 bp, which
removes a potential ETS binding site (EBS), decreased luciferase
activity by 80%, indicating that an important cis-regulatoryImmunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc. 923
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Figure 2. Identification of ETS1-Dependent Genes in NK Cells
(A) Microarray analysis of mRNA from Rag2/Ets1+/+ and Rag2/Ets1/ mNK cells. Probe sets with differential expression in mNK cells are shown as is their
mRNA expression across multiple hematopoietic cell populations.
(B) Analysis of ETS1 binding to ETS1-dependent NK cell genes in a CD4+ T cell line by ChIP-seq. Genes associatedwith ETS1-bound regions were determined by
the closest TSS. Pie graphs show the percent of ETS1-dependent NK genes that had human orthologs (left) and the number of genes that were bound by ETS1
(right).
(C) MEME analysis of sequences bound by ETS1 in ETS1-dependent NK cell genes.
(D) KEGG analysis for functional pathways regulated by NK cell genes with a 1.53 threshold of differential expression.
See Table S1 for ETS1-dependent NK cell genes.
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ETS1 Targets in NK Cellselement was deleted (Figure 4A). Mutation of this EBS in the
context of the 670 bp or 225 bp promoter decreased luciferase
activity by 45% and 68%, respectively, demonstrating that an
ETS family protein was important for Idb2 transcription in this
NKP line (Figure 4A).
The putative EBS in the Idb2 promoter was identified previ-
ously as a target of the EWS-FLI1 and EWS-ERG fusion proteins
found in Ewing’s sarcoma (Nishimori et al., 2002). FLI1 and ERG
are members of a different clade of ETS family proteins and they
have a DNA binding preference distinct from ETS1; therefore, it
was not evident that ETS1 should regulate Idb2 through this
EBS. However, the Idb2 EBS fits a consensus motif bound by
multiple ETS family proteins including ETS1, ELF1, and GABPa
(Hollenhorst et al., 2007, 2009). Electrophoretic mobility shift
assays (EMSA) confirmed that both ETS1 and ELF1were present
in the NKP extract and were able to bind the Idb2 promoter EBS
whereas MEF1 (Lacorazza et al., 2002) was not present in the
bound complex (Figure 4B). Importantly, in mNK cells we
detected binding of ETS1 at the Idb2 promoter indicating that
ETS1 could directly regulate Idb2 (Figure 4C). Analysis of
mRNA at defined stages of NK cell differentiation revealed an
earlier onset of expression for Ets1 mRNA as compared to
Idb2 and Ets1 expression peaks in rNKPs just prior to the peak
of Idb2 at the iNK cell stage (Figure 4D). These data are consis-
tent with the hypothesis that Idb2 mRNA is dependent on ETS1
at the initiation of NK cell lineage specification. Although ID2 is
not essential for early NK cell development, its expression is
one of the first indications of NK cell lineage specification, and
decreased expression of ID2 in Ets1/ mNK cells is predicted924 Immunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc.to have an impact on the differentiation and function of these
cells (Boos et al., 2007).
ETS1 Is Required for Proper Expression and Function
of Multiple Activating NKRs
The few mNK cells present in Ets1/ mice are defective in their
ability to kill cells lacking MHC class 1 molecules (Barton et al.,
1998). However, the mechanism underlying this loss of cytolytic
function is not known. A failure to express activating receptors
or essential components of the signaling machinery activated
by these receptors would explain this defect. Our microarray
analysis revealed decreased expression of genes encoding
the activating receptor NKp46 and multiple Ly49 receptors
(encoded by the Klra genes) as well as proteins involved in signal
transduction by these receptors. We confirmed the decreased
expression of NKp46, Ly49D, and Ly49H on BM and splenic
mNK cells from Ets1/ mice by flow cytometry (Figures 5A and
5B). These activating NKRs were also reduced on Ets1/ mNK
cells isolated from mixed BM chimeras, indicating that this
alteration was cell intrinsic (Figure S3). Therefore, the failure of
Ets1/mNK cells to kill NK cell targets may be, in part, a conse-
quence of decreased expression of multiple activating NKRs.
In contrast to NKp46, Ly49D, and Ly49H, the activating recep-
tors NK1.1 and NKG2D were expressed appropriately on BM
and splenic mNK cells (Figure 5C), suggesting that these recep-
tors are available for NK cell target recognition. To determine
whether these receptors were functional, we tested the ability
of NK1.1 or NKG2D crosslinking to induce degranulation, as
measured by surface CD107a. As expected, crosslinking of
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Figure 3. Deregulation of Multiple NK Cell Genes in the Absence of ETS1
(A) Heat maps for a subset of ETS1-dependent genes in Rag2/Ets1+/+ and Rag2/Ets1/mNK cells (duplicates combined). Asterisk indicates that ETS1 was
bound near this gene by ChIP-seq in CD4 T cells.
(B) qPCR analysis of Tbx21,Ncr1,Cd122, Idb2, Ltb, and Lair1mRNA in Ets1+/+ (black) andEts1/ (white) pro-NK cells (LinCD122+DX5) andmNK cells. At least
three independent experiments were performed.
(C) qPCR analysis of Tbx21 and Ltb mRNA in NKPs. Error bars indicate SD of triplicate measurements. Two independent experiments were performed.
(D) Anti-ETS1 ChIP for EBS in Tbx21 and Cd122. qPCR SP5, Hbb, and Ebf1 are at regions that lack an EBS.
See Table S2 for ETS1 binding sites in CD4+ T cells.
Immunity
ETS1 Targets in NK CellsNK1.1 or NKG2D resulted in increased CD107a compared to
IgG on Ets1+/+ mNK cells (Figures 5D and S3). In contrast,
NKG2D stimulation of Ets1/ mNK cells did not induce
CD107a above that observed with IgG, although CD107a was
higher on IgG-stimulated Ets1/ mNK cells compared to
Ets+/+ mNK cells (Figures 5D and S3). Crosslinking of NK1.1 on
Ets1/ mNK cells increased surface CD107a but the frequency
of CD107a+ cells was lower than observed on Ets1+/+ cells. In
contrast, CD107a was efficiently induced by phorbol myristate
acetate (PMA) + ionomycin in both Ets1+/+ and Ets1/ mNK
cells (Figures 5D and S3). These observations indicated that
Ets1/ mNK cells were intrinsically defective in their ability to
degranulate in response to activating NKR stimulation. In
contrast, interferon-g (IFN-g) production was not as severely
affected, although crosslinking of NKG2D did not lead to a signif-
icant accumulation of IFN-g at this time point in Ets1+/+ or
Ets1/ mNK cells (Figures 5E and S3). The reduced expression
of many activating NKRs and the impaired exocytosis function in
Ets1/mNK cells is sufficient to explain the decreased cytolytic
function of these cells.
Ets1–/– NK Cells Have Characteristics of Chronic
Cytokine Stimulation
In addition to the ETS1-dependent genes, we noted that multiple
genes associated with NK cell activation were increased inEts1/mNK cells.Gzmb andPrf1mRNA, encoding the cytolytic
proteins GZMB (GranzymeB) and PRF (Perforin), were increased
as were mRNAs encoding the serine protease inhibitors
SERPINB6A and SERPINB9B (Figure 6A). We confirmed that
GzmbmRNA was increased in Ets1/ mNK cells by qPCR (Fig-
ure 6B). Nfil3 mRNA, encoding a cytokine-responsive transcrip-
tion factor (Gascoyne et al., 2009; Kamizono et al., 2009), was
also increased in Ets1/ mNK cells as well as in pro-NK cells
(Figures 6A and 6C). Interestingly, Ikzf2 mRNA, which encodes
HELIOS, whose increased expression contributes to hyperres-
ponsiveness in Noe´ mice (NKp46-deficient) (Narni-Mancinelli
et al., 2012), was increased in Ets1/ mNK cells (Figures 6A
and 6D). Ets1/ mNK cells isolated from mixed BM chimeras
also showed increased granularity and increased expression of
the activation marker CD69 as measured by flow cytometry (Fig-
ure 6E). Taken together, these data indicate that Ets1/ mNK
cells are in an activated state.
Our observation that at least two IL-15-regulated genes are
increased in Ets1/ mNK cells led us to question whether these
cells have other characteristics of chronic cytokine stimulation.
Chronic IL-15 stimulation leads to increased expression of the
inhibitory NKRs Ly49G2 and Ly49E (Ly49E is normally not
expressed on adult mNK cells) (Barao et al., 2011; Elpek et al.,
2010; Fraser et al., 2002). We found an increased frequency of
BM mNK cells expressing Ly49G2 and Ly49E but not Ly49A inImmunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc. 925
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Figure 4. Idb2 Is Regulated by ETS1 in NK Cells and Their Precursors
(A) Promoter-luciferase reporter assay via regions 50 of the Idb2 TSS, including the endogenous EBS site (GGA) or a mutated (m) EBS (GGT). One representative
experiment from at least four is shown.
(B) EMSA of proteins in PTL cell extracts binding to the Idb2 EBS in the presence (+) or absence () of cold competitor or a-ETS1, a-MEF1, or a-ELF1.
(C) ChIP was performed on sorted splenic mNK cells via a-ETS1 followed by qPCR with primers flanking the EBS in Idb2 or for sequences lacking an EBS (SP5,
Hbb, and Ebf1).
(D) qPCR analysis for Idb2, Ets1, Elf1, and Gabpa mRNA relative to Hprt mRNA in sorted NK cell and NK cell progenitor populations.
Error bars represent standard error of triplicate measurements and one of at least two to three replicate experiments is shown. See Figure S2 for Ets1 mRNA
expression in NK cell lines and activated NK cells.
Immunity
ETS1 Targets in NK CellsEts1/ as compared toWTmice (Figures 6F and 6G). The inten-
sity of Ly49G2 and Ly49E staining was also increased on Ets1/
mNK cells in both the BM and spleen (Figure 6F). These alter-
ations in inhibitory NKR expression were cell intrinsic as shown
by the fact that they were observed on Ets1/ mNK cells in
mixed BM chimeras (Figure S4). Taken together with the
increased expression of Nfil3, Gzmb, and Prf1 mRNA and
CD69, our findings indicate that Ets1/ mNK cells resembled
NK cells chronically stimulated by IL-15.
Ets1–/– mNK Cells Are Hyperresponsive to IL-15
Given the phenotype of Ets1/ mNK cells, we questioned how
Ets1/ NK cells would respond to cytokines. Single-cell anal-
ysis of Ets1/ and Ets1+/+ DX5 and DX5+ NK cells cultured
in vitro revealed that a comparable frequency of cells could
form colonies in response to IL-2 (Figure 7A). However, Ets1/
colonies were larger and the cells were more granular than their
WT counterparts (Figure 7B). To determine whether Ets1/
mNK cells were more responsive to IL-15 than WT mNK cells,
we titrated IL-15 in cultures of Ets1/ and Ets1+/+ mNK cells
and measured induction of GZMB and proliferation by means
of BrdU incorporation. Within 24 hr, Ets1/ mNK cells showed
an increase in GZMB and BrdU incorporation compared to
Ets1+/+ mNK cells at all concentrations of IL-15 (Figure 7C).
The augmented response of Ets1/ mNK cells was particularly
evident when IL-15 was present at 50 ng/ml, the concentration
commonly used for expansion of NK cells in vitro (Figures 7C
and 7D). In addition, whereas Ets1+/+ mNK cells showed little
induction of GZMB or BrdU incorporation when cultured in926 Immunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc.1 ng/ml IL-15, Ets1/ mNK cells showed a 4-fold higher
response (Figures 7C and 7D). These experiments were
performed with mNK cells isolated from mixed BM chimeras,
allowing us to exclude in vivo homeostatic proliferation as a
factor predisposing Ets1/ mNK cells to an increased cytokine
response. Taken together with the data in Figure S2, showing
thatEts1mRNAdecreasedwhenNKcellswere stimulated in vivo
for 2 days with IL-2 or 1 day with poly(I:C), our findings suggest
a role for ETS1 in limiting NK cell activation in response to
cytokines. Our data support a model in which ETS1 controls
expression of a broad spectrum of NK cell genes including
transcription factors, NKRs, and signaling molecules at the
earliest stages of NK cell development, allowing for appropriate
NK cell activation in pathogenic conditions.
DISCUSSION
In this study, we have revealed at least three major functions for
ETS1 in NK cells. First, ETS1 directly regulates expression of
Idb2 and Tbx21, whose protein products ID2 and T-BET
comprise a part of the transcriptional circuitry necessary for
NK cell differentiation. Second, ETS1 is required for expression
and function of multiple activating NKRs that are necessary for
induction of NK cell-mediated cytolysis. This functional deficit
was revealed primarily as a failure of degranulation rather than
IFN-g production. Thus, the inability of Ets1/ NK cells to kill
NK cell targets can be explained by their decreased ability
to degranulate in response to activating NKR ligands. Third,
ETS1 sets the threshold for responsiveness to cytokine, and
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ETS1 Targets in NK Cellsprobably other external stimuli, which may prevent expansion
and activation in nonpathogenic conditions. In the absence of
ETS1, mNK cells had hallmarks of chronic IL-15 stimulation
and they had a heightened response to a suboptimal dose of
IL-15. Taken together, our data provide insight into the functions
of this critical transcriptional regulator in NK cells and provide
a foundation on which to build the regulatory circuits driving
NK cell development and function.
The absence of ETS1 resulted in alterations in NK cell progen-
itors at the earliest stages of development, placing ETS1, along
with ID2, TOX1, and E4BP4 (Aliahmad et al., 2010; Kamizono
et al., 2009), as the earliest acting transcriptional regulators
identified in NK cells. We showed that Ets1 mRNA expression
precedes Idb2 mRNA, which was previously the earliest known
marker of NK cell differentiation. Therefore, ETS1 is positioned
to play a key role in NK cell lineage specification. In order for
ETS1 to function in NK cell specification, its expression should
precede NK cell lineage restriction. We previously found that
Ets1 was among the genes primed by E2A in LMPPs (Dias
et al., 2008). During specification of the NK cell lineage, E2A
function is antagonized by ID2 and ID3 (Boos et al., 2007) and
yet Ets1 mRNA increases. Therefore, the transcription factors
controlling Ets1 must evolve as the NK cell fate is specified.
This shift in transcriptional control could occur as a consequence
of the induction of NK cell-associated transcription factors such
as T-BET, or alternatively, ETS1 may autoregulate its own
expression (Hollenhorst et al., 2009; Seth and Papas, 1990).There are multiple ETS1 binding events near the Ets1 gene in
CD4+ T cells, indicating that ETS1 may control its own expres-
sion (Hollenhorst et al., 2009). Based on these considerations
and our current knowledge of transcriptional networks in B and
T cell development (Nutt and Kee, 2007), we hypothesize that
ETS1 functions in a transcriptional network with re-enforcing
feedback loops to control NK cell lineage specification.
It is important to note that although NKP cell numbers in
Ets1/ mice were indistinguishable from Ets1+/+ mice, more
highly enriched progenitor populations revealed a requirement
for ETS1. However, identification of pre-NKP, rNKP, and pre-
pro-NK cells relies on expression of surface proteins reported
to be ETS1 targets, raising the possibility that altered gene
expression rather than altered development is responsible for
this decrease. CD127 (IL-7Ra) is critical for identification of these
cells and was reported to be an ETS1 target in peripheral CD8+
T cells (Grenningloh et al., 2011). Importantly, we did not find
decreased CD127 on Ets1/CLPs via multiple different staining
strategies or within the larger LinCD244+CD27+ population
containing NK cell progenitors. Therefore, ETS1 is not essential
for CD127 expression in multipotent progenitors of NK cells.
Nonetheless, if CD127 were an ETS1 target in the earliest
NK cell progenitors, this would further support our conclusion
that ETS1 controls gene expression at this early stage of NK
cell development.
We have defined a minimal set of high-probability ETS1 target
genes by correlating ETS1-dependent gene expression withImmunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc. 927
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ETS1 Targets in NK CellsETS1 DNA binding events in a CD4+ T cell line. This is a minimal
set because not all ETS1-dependent NK cell genes are
expressed in CD4+ T cells; therefore, ETS1 binding could not
be assessed at all NK cell targets. Nonetheless, 49% of ETS1-
dependent NK cell genes were bound by ETS1 in CD4+ T cells,
probably reflecting overlapping functions for ETS1 in these cell
types. Indeed, ETS1 regulates genes involved in T cell activation
in CD4+ T cells (Hollenhorst et al., 2007, 2009), and we identified
‘‘T cell receptor signaling’’ in addition to ‘‘NK cell cytotoxicity’’
as pathways associated with ETS1-dependent genes in
NK cells. Consistent with this common function, we found that
ETS1-regulated NK genes had ETS binding motifs nearly iden-
tical to an ETS1-specific motif reported in T cell studies (Hollen-
horst et al., 2007, 2009). However, although this site was not
associated with ELF1 binding in CD4+ T cells, it shows similari-
ties to ETS binding motifs reported for other ETS family proteins
(Hollenhorst et al., 2009; Wei et al., 2010). We speculate that
other ETS factors may occupy some of these sites in the928 Immunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc.absence of ETS1, providing an explanation for the only partial
decrease in many putative ETS1 target genes in Ets1/
mNK cells. In addition, some genes, such as Idb2, have an
ETS binding motif that can be bound by ELF1 and other ETS
family proteins (Hollenhorst et al., 2009), and we found ELF1
binding to this site in an NKP line. Therefore, ETS family proteins
probably play a more crucial role in NK cell development than
revealed by the Ets1/ mouse.
An emerging question is why ETS1 induces some genes
specifically in NK cells but not in T cells and B cells, where it is
also expressed (Eyquem et al., 2004a, 2004b). The unique chro-
matin landscape present in each of these cells undoubtedly
plays an important role. However, there are also factors that
may influence ETS1 target gene selection such as ETS1 concen-
tration and DNA sequence affinity (Hollenhorst et al., 2007,
2009), posttranslational modification (Cowley and Graves,
2000; Lee et al., 2008), DNA methylation (Gaston and Fried,
1995; Yokomori et al., 1995), and cooperative interactions with
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(A) Percent of single Ets1+/+ (filled) and Ets1/
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colonies after 10 days in cultures supplemented
with IL-2.
(B) FSC versus SSC on typical mNK cell progeny
from (A).
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Immunity
ETS1 Targets in NK Cellsneighboring transcription factors (Cowley and Graves, 2000;
Pufall et al., 2005). In T cells, ETS1 and RUNX1 bind coopera-
tively at the Tcra enhancer, and in B cells, ETS1 is recruited to
the Cd79b promoter via association with PAX5 (Fitzsimmons
et al., 2009; Hollenhorst et al., 2009). Future studies analyzing
cis-regulatory elements at shared and NK cell-specific ETS1
targets could provide insight into the mechanisms of lineage-
specific gene expression by ETS proteins. Our study provides
a critical first step in this analysis by identifying potential shared
and NK cell-specific ETS1 target genes.
Multiple observations lead us to conclude that ETS1 limits
the NK cell response to cytokines. In addition to having an acti-
vated phenotype, Ets1/NK cells showed elevated Nfil3mRNA
and Nfil3 is regulated downstream of IL-15 and is sufficient to
rescue NK cell differentiation in Il15ra/ NKPs cultured in vitro
(Gascoyne et al., 2009; Kamizono et al., 2009). Ly49G2 and
Ly49E were both highly expressed on Ets1/ compared to
Ets1+/+mNK cells and their expression is upregulated by chronic
cytokine stimulation (Barao et al., 2011; Elpek et al., 2010; FraserImmunity 36, 921–9et al., 2002). Moreover, in in vitro
cytokine-dependent cultures, Ets1/
NK cells cloned well with larger colony
sizes compared to Ets1+/+ NK cells and
both in vitro and in vivo, and under
competitive reconstitution conditions,
Ets1/ NK cells had an activated pheno-
type. Most importantly, however, Ets1/
mNK cells incorporated more BrdU and
induced GZMB more rapidly than WT
mNK cells at all concentrations of IL-15.
The mechanism underlying the height-
ened activation in Ets1/ NK cells prob-
ably involves the deregulation of multiple
genes encoding signaling proteins and
transcription factors (for example, Itk,
Jak1, Lck, Ppp1r3b, Ptpn3, Egr3, Tbx21,
Ikzf2, or Nfat1c). In addition, the
decreased expression and function of
activating NKRsmay change the ‘‘tuning’’
of the intracellular signaling milieu, result-
ing in an altered response to multiple cellsurface receptors (Joncker et al., 2009; Joncker and Raulet,
2008). Indeed, mice lacking NKp46 are hyperresponsive to
MCMV and the NK cell target YAC-1 and their increased respon-
siveness requires HELIOS (Narni-Mancinelli et al., 2012), which
is increased in Ets1/ NK cells and therefore probably contrib-
utes to the hyperresponsive phenotype. However, in Ets1/
mNK cells the compounded defects in activating receptor
expression and degranulation probably limited NK cell-mediated
lysis. The hypothesis that ETS1 influences lymphocyte activation
potential is consistent with a previously reported role for ETS1 in
the B cell response to TLR9 (John et al., 2008; Wang et al., 2005).
Moreover, ETS1 influences cytokine responsiveness and activa-
tion in T lymphocytes (Clements et al., 2006; Grenningloh et al.,
2005; Higuchi et al., 2007; Moisan et al., 2007; Russell and Gar-
rett-Sinha, 2010), indicating that targets of ETS1 contribute to
the signaling milieu in adaptive lymphocytes. The barrier to
NK cell activation imposed by ETS1 may reflect involvement of
ETS1 targets in the unique mechanisms controlling NK cell
activation because Ets1/ T cells fail to become activated after32, June 29, 2012 ª2012 Elsevier Inc. 929
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ETS1 Targets in NK Cellsstimulation (Muthusamy et al., 1995). Importantly, although ETS1
deficiency phenocopies many aspects of chronic cytokine stim-
ulation, Ets1/ mice do not develop leukemia as was observed
in IL-15 transgenic mice (Fehniger et al., 2001). Leukemogenesis
may be limited by the arrested differentiation that accompanies
ETS1 deficiency at the earliest stages of NK cell development.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 or 129/SvJ Ets1/ mice (Barton et al., 1998) were housed at the
University of Chicago Animal Resources Center in accordance with the guide-
lines of the University of Chicago Institutional Animal Care andUseCommittee.
129/SvJ Rag2/ mice were purchased from Jackson Labs.
Quantitative Real-Time PCR
RNA was purified with the RNeasy micro kit (QIAGEN), reverse transcribed
with SuperScriptIII (Invitrogen), and primed with random hexamers as
described (Boos et al., 2007). Expression is reported as DCT relative to Hprt
mRNA. qPCR primer sequences are available upon request.
Luciferase Reporter Assays
The 670 bp and 225 bp Idb2 promoter fragments were PCR amplified from
genomic DNA and cloned into pGL3. The 130 bp Idb2 fragment was digested
from pGL3-225-Idb2p with SacI and XhoI and cloned into pGL3. PTL cells
were transfected with DEAE-dextran with 8 mg of pGL3 constructs and
0.5 mg of pRL-CMV as an internal control (Kee and Murre, 1998). Lysates
were prepared 48 hr after transfection and assayed with the Dual-Glo Lucif-
erase kit (Promega).
Electrophoretic Mobility Shift Analysis
Nuclear extracts were prepared and EMSA performed as described (Kee and
Murre, 1998). The Idb2 EBS sequence was 50-GGTATTGGCTGCGAACGCG
GAAGAACC-30 and the Idb2 EBS mutant sequence was 50-GGTATTGGCT
GCGAACGCGGTAGAACC-30. Antibodies to ETS1, ELF1, and MEF1 were
purchased from Santa Cruz Biotechnology.
Cell Culture
Cells lines were maintained in Opti-MEM or RPMI-1640 supplemented with
10% FBS, 80 mM 2-mercaptoethanol, 100 units/ml penicillin, 100 mg/ml strep-
tomycin, and 29.2 mg/ml glutamine. Primary NKPs were grown on OP9
stromal cells (10,000 OP9 cells/well of a 96-well plate) supplemented with
IL-2 (1,000 IU/ml, NIH Reagents program), CD117 (1:1,000 dilution from
CHO-MGF cells), and FLT3 (10 ng/ml). Primary mNK cells and NK cell lines
were cultured in media supplemented with IL-2. The PTL line was generated
by H.-R. Rodewald by in vitro culture of fetal thymus-derived FcRgII or FcRgIII+
NK and T cell progenitors (Rodewald et al., 1992) and was adapted for growth
in Opti-MEM. The KY1, KY2, and NKCRq cell lines were provided by
W. Yokoyama and C. Roth (Caraux et al., 2006; Karlhofer et al., 1995).
IL-15 responsiveness was determined by culturing 1,500–3,000 flow cytom-
etry-sorted splenicmNK cells, isolated from chimericmice, inmultiple concen-
trations of recombinant mIL-15. At t = 24 hr, 1 mM BrdU was added for 45 min
prior to intracellular staining for BZMB and BrdU.
Flow Cytometry
Cells were stained with fluorochrome- or biotin-labeled antibodies for 20 min
on ice. The following antibodies conjugated to FITC, PE, PerCP-Cy5.5,
PerCP-ef710, PeCy7, APC, APC-ef780, Pacific Blue, or Brilliant Violet 421
were purchased from eBioscience, BD PharMingen, or Biolegend: CD45.2
(104), CD45.1 (A20), CD19 (1D3), B220 (Ra3-6B2), CD3ε (145-2C11), CD4
(RM4-5), CD8a (Ly-2), TCR-b (H57-597), TCR-gd (UC7-13D5), CD11b (M1/
70), Ter-119 (Ly-76), Gr-1 (RB6-8C5), IL-7Ra (A7R34), CD117 (2B8), Sca1
(E13-161.7), FLT3 (A2F10), CD122 (TM-b1), NK1.1 (PK136), CD49b (DX5),
CD94 (18d3), NKG2ACE (20d5), NKp46 (29A1.4), Klrg1 (CF1), CD69
(H1.2F3), Ly49D (4E5), Ly49H (3D10), Ly49G2 (ebio4D11), Ly49A (A1), LyEF
(CM4), Ly49CIFH (14B11), Ly-6d (49-H4), CD27 (LG.7F9), Klrg1 (2F1), BrdU
(Bu20a or PRB-1), IFN-g (XMG1.2), GZMB (NGZB or 16G6), and 2B4930 Immunity 36, 921–932, June 29, 2012 ª2012 Elsevier Inc.(ebio244F4). Propidium idodide was used to exclude dead cells. Cells were
analyzed on a FACS Canto, LSRII, or Fortessa or sorted with a FACS ARIAII
(Becton Dickenson).
Lineage cocktail for HSC, MPP, LMPP, CLPs: B220, CD3ε, CD4, CD8,
NK1.1, Ter119, CD11b, Ly-6G; for NK cells: CD19, CD3ε, CD4, CD8,
Ter119; and for CLP, pre-NKP, rNKP populations: CD19, CD11b, CD3ε,
Ly6d, and NK1.1.
NK Cell Activation
In vivo activation of NK cells was accomplished by an intravenous (i.v.)
injection of 1,000,000 IU IL-2 at t = 0 and t = 24 hr. At t = 48 hr, NK cells
were isolated by flow cytometry. Alternatively, 100 mg of poly(I:C) was injected
intraperitoneally (i.p.) followed by isolation of NK cells at t = 24 hr. For a-NK1.1,
a-NKG2D, or IgG stimulation of NK cells, mNK cells were cultured on antibody-
coated plates in 1,000 IU/ml IL-2 plus Golgi Plug (Becton Dickenson) for
5 hr. Fluorochrome-labeled a-CD107a (1D4B) or isotype control antibodies
(5 mg/ml) were added at t = 0. Cells were stained with DX5 and NKp46 prior
to flow cytometry analysis. Alternatively, cells were cultured with PMA
(100 ng/ml) and ionomycin (2 mM).
BM Chimeras
Chimeric mice were established by retrorbital injection of 2.5 3 106 bone
marrow cells from CD45.1 WT mice and 2.5 3 106 bone marrow cells from
CD45.2 Ets1+/+ or CD45.2 Ets1/ mice into 8-week-old lethally irradiated
(1,000 rad) CD45.1 and CD45.2 or CD45.1 recipients. Recipients were
maintained on Bactrim and analyzed 8 weeks posttransplantation.
Microarray Analysis
cDNA prepared from 10,000 LinCD122+DX5+ cells was used to probe
Affymetrix MOE 430_2 arrays as previously described (Dias et al., 2008).
Raw array data were normalized with RMAexpress (http://rmaexpress.
bmbolstad.com/) and analyzed by dChip (http://www.biostat.harvard.edu/
complab/dchip/). Probe set annotation was obtained from Affymetrix.
MEME
Multiple Em for Motif Elicitation was used to identify repeated motifs in ETS1
ChIP-Seq sequences from the CD4+ T cell line Jurkat. MEME was run with
default setting, except that the minimum motif length was set to 8 and
maximum to 15. Only the motifs with the lowest E-value are reported.
Chromatin Immunoprecipitation
Primary mouse mNK cells were crosslinked in 1% formaldahyde and sheared
on a Branson sonicator. Protein-DNA complexes were immunoprecipitated
with polyclonal anti-ETS1 (C-20) or IgG (Santa Cruz). For each sample,
1,000,000 cell equivalents of chromatin were incubated with 5 mg of antibody.
Protein G-coupled magnetic beads were used to isolate immune complexes.
Crosslinks were reversed by heating at 65C followed by proteinase K treat-
ment. DNA was purified with PCR spin columns (QIAGEN) and amplified
by qPCR with primers specific for the Tbx21, Cd122, or Idb2 EBS or irrelevant
genomic regions (SP5, Hbb, Ebf1). ChIP sequencing was described in Hollen-
horst et al. (2009).
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE37301.
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